Abstract
This study aimed to estimate syphilis prevalence among people who are pregnant with live births by race and ethnicity 2014–2022. We analyzed data on syphilis infection from birth certificates using a Bayesian model, adjusting for test sensitivity, specificity, and screening coverage. We estimated syphilis prevalence among people who are pregnant with live births increased from 88.7 (95% UI: 77.3–104.7) per 100,000 live births in 2014 to 462.2 (95% UI: 430.9–502.4) per 100,000 live births in 2022. With rising prevalence, relative racial and ethnic disparities narrowed over time. Syphilis prevalence is likely higher among women with stillbirths, indicating a need for improved screening and interventions.
One sentence summary line We estimated an increasing syphilis prevalence among people who are pregnant, reaching 462 per 100,000 live births in 2022, and notable racial and ethnic disparities in prevalence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available data from published literature cited and databases that were originally located at the National Center for Health Statistics (https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm), Sexually Transmitted Infections Surveillance 2022 (https://www.cdc.gov/std/statistics/2022/default.htm), and NCHHSTP AtlasPlus (https://www.cdc.gov/nchhstp/about/atlasplus.html?CDC_AAref_Val=https://www.cdc.gov/nchhstp/atlas/index.htm).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online at https://github.com/Yizhi-Liang/Trends-Syph.
